Show simple item record

dc.contributor.authorMorris, M.en
dc.contributor.authorCook, A.en
dc.contributor.authorDodkins, J.en
dc.contributor.authorPrice, D.en
dc.contributor.authorWaller, S.en
dc.contributor.authorHassan, S.en
dc.contributor.authorNathan, A.en
dc.contributor.authorAggarwal, A.en
dc.contributor.authorPayne, H. A.en
dc.contributor.authorClarke, Noelen
dc.contributor.authorvan der Meulen, J.en
dc.contributor.authorNossiter, J.en
dc.date.accessioned2024-06-27T07:21:00Z
dc.date.available2024-06-27T07:21:00Z
dc.date.issued2024en
dc.identifier.citationMorris M, Cook A, Dodkins J, Price D, Waller S, Hassan S, et al. What can patient-reported experience measures tell us about the variation in patients' experience of prostate cancer care? A cross-sectional study using survey data from the National Prostate Cancer Audit in England. BMJ open. 2024 Feb 28;14(2):e078284. PubMed PMID: 38418235. Pubmed Central PMCID: PMC10910410. Epub 2024/02/29. eng.en
dc.identifier.pmid38418235en
dc.identifier.doi10.1136/bmjopen-2023-078284en
dc.identifier.urihttp://hdl.handle.net/10541/626953
dc.description.abstractOBJECTIVES: A national survey aimed to measure how men with prostate cancer perceived their involvement in and decisions around their care immediately after diagnosis. This study aimed to describe any differences found by socio-demographic groups. DESIGN: Cross-sectional study of men who were diagnosed with and treated for prostate cancer. SETTING: The National Prostate Cancer Audit patient-reported experience measures (PREMs) survey in England. PARTICIPANTS: Men diagnosed in 2014-2016, with non-metastatic prostate cancer, were surveyed. Responses from 32 796 men were individually linked to records from a national clinical audit and to administrative hospital data. Age, ethnicity, deprivation and disease risk classification were used to explore variation in responses to selected questions. PRIMARY AND SECONDARY OUTCOME MEASURES: Responses to five questions from the PREMs survey: the proportion responding to the highest positive category was compared across the socio-demographic characteristics above. RESULTS: When adjusted for other factors, older men were less likely than men under the age of 60 to feel side effects had been explained in a way they could understand (men 80+: relative risk (RR)=0.92, 95% CI 0.84 to 1.00), that their views were considered (RR=0.79, 95% CI 0.73 to 0.87) or that they were involved in decisions (RR=0.92, 95% CI 0.85 to 1.00). The latter was also apparent for men who were not white (black men: RR=0.89, 95% CI 0.82 to 0.98; Asian men: RR=0.85, 95% CI 0.75 to 0.96) and, to a lesser extent, for more deprived men. CONCLUSIONS: The observed discrepancies highlight the need for more focus on initiatives to improve the experience of ethnic minority patients and those older than 60 years. The findings also argue for further validation of discriminatory instruments to help cancer care providers fully understand the variation in the experience of their patients.en
dc.language.isoenen
dc.relation.urlhttps://dx.doi.org/10.1136/bmjopen-2023-078284en
dc.titleWhat can patient-reported experience measures tell us about the variation in patients' experience of prostate cancer care? a cross-sectional study using survey data from the national prostate cancer audit in Englanden
dc.typeArticleen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchester, Manchester, UK.en
dc.identifier.journalBMJ Openen
dc.description.noteen]
refterms.dateFOA2024-07-01T11:03:49Z


Files in this item

Thumbnail
Name:
What can patient....pdf
Size:
905.4Kb
Format:
PDF
Description:
Found with Open Access Button

This item appears in the following Collection(s)

Show simple item record